3 Penny Stocks Insiders Are Buying

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Emmaus Life Sciences

The Trade: Emmaus Life Sciences, Inc. EMMA Chairman and CEO Yutaka Niihara acquired a total of 9701 shares at an average price of $1.55. To acquire these shares, it cost $15,021.55.

What’s Happening: The company’s stock has jumped over 18% since the start of the year.

What Emmaus Life Sciences Does: Emmaus Life Sciences Inc is a biopharmaceutical company engaged in the discovery, development, and commercialization of new treatments and therapies primarily for rare and orphan diseases.

Flotek Industries

The Trade: Flotek Industries, Inc. FTK CEO and President John Gibson Jr acquired a total of 2000 shares shares at an average price of $1.37. The insider spent $2,740.00 to buy those shares.

What’s Happening: The company, last month, results for its second quarter.

What Flotek Industries Does: Flotek Industries delivers chemistry-based technology solutions for energy, industrial, and consumer applications.

Optex Systems

The Trade: Optex Systems Holdings, Inc OPXS Director Dale E Lehmann acquired a total of 23158 shares at an average price of $1.50. To acquire these shares, it cost $34,766.50.

What’s Happening: The company’s shares gained around 5% over the previous month.

What Optex Systems Does: Optex Systems Holdings manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets.

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksInsider TradesPre-Market OutlookMarketsTrading IdeasPenny Stocks Insider Buying
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...